NYT :: Health

Pfizer Acquires Rights to Alzheimer?s Drug

Pfizer said that it was acquiring the rights to Dimebon, a promising experimental drug for Alzheimer?s disease, from Medivation for as much as $725 million.<br/><br/><span class="advertisement"> <a href="http://www.pheedo.com/click.phdo?x=07ef2180cee44d9abb689f9f7fe272d1&u=http://www.nytimes.com/2008/09/04/business/04drug.html"><img src="http://www.pheedo.com/img.phdo?x=07ef2180cee44d9abb689f9f7fe272d1&u=http://www.nytimes.com/2008/09/04/business/04drug.html" border="0"/></a></span>